Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fuji
McKesson
McKinsey
Johnson and Johnson
Daiichi Sankyo

Generated: March 18, 2019

DrugPatentWatch Database Preview

Lantheus Medcl Company Profile

« Back to Dashboard

What is the competitive landscape for LANTHEUS MEDCL, and when can generic versions of LANTHEUS MEDCL drugs launch?

LANTHEUS MEDCL has nine approved drugs.

There are five US patents protecting LANTHEUS MEDCL drugs.

There are eighty patent family members on LANTHEUS MEDCL drugs in thirty-four countries and twelve supplementary protection certificates in eight countries.

Summary for Lantheus Medcl
International Patents:80
US Patents:5
Tradenames:9
Ingredients:8
NDAs:9

Drugs and US Patents for Lantheus Medcl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Lantheus Medcl XENON XE 133 xenon xe-133 GAS;INHALATION 017284-001 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Lantheus Medcl THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INTRAVENOUS 017806-002 Oct 9, 1998 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lantheus Medcl THALLOUS CHLORIDE TL 201 thallous chloride tl-201 INJECTABLE;INJECTION 017806-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lantheus Medcl TECHNELITE technetium tc-99m sodium pertechnetate generator SOLUTION;INTRAVENOUS 017771-002 Feb 12, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lantheus Medcl GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 017478-001 Approved Prior to Jan 1, 1982 BS RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Lantheus Medcl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 4,894,445 ➤ Try a Free Trial
Lantheus Medcl ABLAVAR gadofosveset trisodium SOLUTION;INTRAVENOUS 021711-002 Dec 22, 2008 7,011,815 ➤ Try a Free Trial
Lantheus Medcl ABLAVAR gadofosveset trisodium SOLUTION;INTRAVENOUS 021711-002 Dec 22, 2008 8,394,356 ➤ Try a Free Trial
Lantheus Medcl CARDIOLITE technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-001 Dec 21, 1990 4,452,774 ➤ Try a Free Trial
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 6,773,696 ➤ Try a Free Trial
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 6,528,039 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Lantheus Medcl Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0806968 PA2007003 Lithuania ➤ Try a Free Trial PRODUCT NAME: GADOFOSVESETUM TRINATRICUM; REG NO/DATE: EU/1/05/313/001-009 20051005
0712293 SPC/GB07/031 United Kingdom ➤ Try a Free Trial PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
0806968 SPC 037/2006 Ireland ➤ Try a Free Trial SPC 037/2006: 20070528, EXPIRES: 20201002
0806968 300253 Netherlands ➤ Try a Free Trial 300253, 20160116, EXPIRES: 20201002
0806968 SPC/GB07/011 United Kingdom ➤ Try a Free Trial PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003
0806968 CA 2007 00016 Denmark ➤ Try a Free Trial
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Queensland Health
Boehringer Ingelheim
Baxter
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.